Skip to content

Roivant Sciences ROIV Debt-to-assets

Debt-to-assets at other companies

Amgen logo
AmgenAMGN
0.6×0.0×
Moderna logo
ModernaMRNA
0.1×+0.1×
Royalty Pharma logo
Royalty PharmaRPRX
0.5×0.0×
ALN
Alnylam PharmaceuticalsALNY
0.1×0.0×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.1×0.0×
Incyte logo
IncyteINCY
0.0×

Other financials

Income statement

See full
Revenue$2.5M-66.7%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$22.61B+175%
Enterprise value$21.29B+157%
P/S2,736.9×+2,454×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Calculated from Roivant Sciences’s reported figures.

Based on the most recent quarter.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's debt-to-assets?
Roivant Sciences (ROIV) reported debt-to-assets of 0× in Q1 2026.
How has Roivant Sciences's debt-to-assets changed year-over-year?
Roivant Sciences's debt-to-assets increased by 2.2% year-over-year, from 0× to 0×.
What is the long-term trend for Roivant Sciences's debt-to-assets?
Over 4 years (2021 to 2025), Roivant Sciences's debt-to-assets has grown at a -33.6% compound annual growth rate (CAGR), from 0.4× to 0.1×.
What does debt-to-assets mean?
What fraction of everything the company owns is funded by debt.
How do you interpret debt-to-assets?
A lower ratio indicates a more conservatively financed balance sheet. Rising debt-to-assets over time signals increasing financial risk.
How does debt-to-assets compare across companies?
Comparable within an industry; bounded between 0 and 1 for most non-financials, which makes cross-company reads cleaner than debt-to-equity.